The feasibility of a method of magnetic resonance (MR)-guided sclerotherapy for hemangioma was evaluated. The distribution of a test injection and a contiguous sclerosant injection was monitored clearly with MR fluoroscopy. Postsclerotherapy T2-weighted MR images depicted areas with and those without effective sclerosant concentration, which enabled performance of selective supplemental sclerotherapy. This method of MR-guided sclerotherapy seems feasible for clinical application.